{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:16:59Z","timestamp":1740107819111,"version":"3.37.3"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T00:00:00Z","timestamp":1682294400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T00:00:00Z","timestamp":1682294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s10157-023-02348-8","type":"journal-article","created":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T16:02:47Z","timestamp":1682352167000},"page":"660-671","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Anti-SARS-CoV-2 IgG antibody titer after BNT162b2 mRNA COVID-19 vaccination in Japanese patients who underwent renal replacement therapy, hemodialysis, peritoneal dialysis, and kidney transplantation"],"prefix":"10.1007","volume":"27","author":[{"given":"Ryohei","family":"Iwabuchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Harada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aiko","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daiki","family":"Aomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosuke","family":"Sonoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideyuki","family":"Nakazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaoko","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etsuko","family":"Mizukami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8077-891X","authenticated-orcid":false,"given":"Yuji","family":"Kamijo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,24]]},"reference":[{"key":"2348_CR1","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine. N Engl J Med. 2020;383:2603\u201315.","journal-title":"N Engl J Med"},{"key":"2348_CR2","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1056\/NEJMoa2101765","volume":"384","author":"N Dagan","year":"2021","unstructured":"Dagan N, Barda N, Kepten E, et al. BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting. N Engl J Med. 2021;384:1412\u201323.","journal-title":"N Engl J Med"},{"key":"2348_CR3","doi-asserted-by":"crossref","unstructured":"2020 Annual dialysis data report, JSDT renal data registry. https:\/\/www.jstage.jst.go.jp\/article\/jsdt\/54\/12\/54_611\/_pdf\/-char\/en. Accessed 1 Nov 2022.","DOI":"10.4009\/jsdt.54.611"},{"key":"2348_CR4","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.35379","volume":"4","author":"S Salerno","year":"2021","unstructured":"Salerno S, Messana JM, Gremel GW, et al. COVID-19 risk factors and mortality outcomes among medicare patients receiving long-term dialysis. JAMA Netw Open. 2021;4: e2135379.","journal-title":"JAMA Netw Open"},{"key":"2348_CR5","unstructured":"Yoshida K. The Japan society for transplantation. Fact book 2021 on Organ Transplantation in Japan. https:\/\/asas.or.jp\/jst\/pdf\/factbook\/factbook2021.pdf. Accessed 1 Nov 2022."},{"key":"2348_CR6","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s10157-021-02156-y","volume":"26","author":"M Matsunami","year":"2022","unstructured":"Matsunami M, Suzuki T, Terao T, et al. Immune response to SARS-CoV-2 vaccination among renal replacement therapy patients with CKD: a single-center study. Clin Exp Nephrol. 2022;26:305\u20137.","journal-title":"Clin Exp Nephrol"},{"key":"2348_CR7","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s10157-022-02261-6","volume":"27","author":"M Matsunami","year":"2023","unstructured":"Matsunami M, Suzuki T, Yashima J, et al. Delayed kinetics of SARS-CoV-2 IgG antibody production in kidney transplant recipients following the third dose of COVID-19 vaccination. Clin Exp Nephrol. 2023;27:98\u20139.","journal-title":"Clin Exp Nephrol"},{"key":"2348_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100529","volume":"3","author":"VV Edara","year":"2022","unstructured":"Edara VV, Manning KE, Ellis M, et al. mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 omicron variant. Cell Rep Med. 2022;3: 100529.","journal-title":"Cell Rep Med"},{"key":"2348_CR9","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.cell.2021.12.032","volume":"185","author":"M Hoffmann","year":"2022","unstructured":"Hoffmann M, Kr\u00fcger N, Schulz S, et al. The omicron variant is highly resistant against antibody-mediated neutralization: implications for control of the COVID-19 pandemic. Cell. 2022;185:447-456.e11.","journal-title":"Cell"},{"key":"2348_CR10","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1038\/s41467-020-16638-2","volume":"11","author":"CM Poh","year":"2020","unstructured":"Poh CM, Carissimo G, Wang B, et al. Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patients. Nat Commun. 2020;11:2806.","journal-title":"Nat Commun"},{"key":"2348_CR11","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1056\/NEJMoa2026920","volume":"383","author":"C Keech","year":"2020","unstructured":"Keech C, Albert G, Cho I, et al. Phase 1\u20132 trial of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine. N Engl J Med. 2020;383:2320\u201332.","journal-title":"N Engl J Med"},{"key":"2348_CR12","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transplant. 2013;48:452\u20138.","journal-title":"Bone Marrow Transplant"},{"key":"2348_CR13","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1093\/ndt\/gfab179","volume":"36","author":"B Simon","year":"2021","unstructured":"Simon B, Rubey H, Treipl A, et al. Haemodialysis patients show a highly diminished antibody response after COVID-19 mRNA vaccination compared with healthy controls. Nephrol Dial Transplant. 2021;36:1709\u201316.","journal-title":"Nephrol Dial Transplant"},{"key":"2348_CR14","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1053\/j.ajkd.2021.08.005","volume":"79","author":"I Bensouna","year":"2022","unstructured":"Bensouna I, Caudwell V, Kubab S, et al. SARS-CoV-2 antibody response after a third dose of the BNT162b2 vaccine in patients receiving maintenance hemodialysis or peritoneal dialysis. Am J Kidney Dis. 2022;79:185-92.e1.","journal-title":"Am J Kidney Dis"},{"key":"2348_CR15","doi-asserted-by":"publisher","first-page":"6850","DOI":"10.1038\/s41598-022-10510-7","volume":"12","author":"K Fujieda","year":"2022","unstructured":"Fujieda K, Tanaka A, Kikuchi R, et al. Antibody response to double SARS-CoV-2 mRNA vaccination in Japanese kidney transplant recipients. Sci Rep. 2022;12:6850.","journal-title":"Sci Rep"},{"key":"2348_CR16","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/s41581-021-00502-7","volume":"17","author":"M Prendecki","year":"2021","unstructured":"Prendecki M, Willicombe M, McAdoo SP. COVID-19 vaccination in patients with immunity-mediated kidney disease. Nat Rev Nephrol. 2021;17:790\u20131.","journal-title":"Nat Rev Nephrol"},{"key":"2348_CR17","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1111\/ene.12132","volume":"20","author":"W Kim","year":"2013","unstructured":"Kim W, Kim SH, Huh SY, et al. Reduced antibody formation after influenza vaccination in patients with neuromyelitis optica spectrum disorder treated with rituximab. Eur J Neurol. 2013;20:975\u201380.","journal-title":"Eur J Neurol"},{"key":"2348_CR18","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/art.25034","volume":"62","author":"CO Bingham 3rd","year":"2010","unstructured":"Bingham CO 3rd, Looney RJ, Deodhar A, et al. Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trial. Arthritis Rheum. 2010;62:64\u201374.","journal-title":"Arthritis Rheum"},{"key":"2348_CR19","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1182\/blood-2013-04-494096","volume":"122","author":"I Nazi","year":"2013","unstructured":"Nazi I, Kelton JG, Larch\u00e9 M, et al. The effect of rituximab on vaccine responses in patients with immune thrombocytopenia. Blood. 2013;122:1946\u201353.","journal-title":"Blood"},{"key":"2348_CR20","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1097\/TP.0000000000004151","volume":"106","author":"A Nimmo","year":"2022","unstructured":"Nimmo A, Gardiner D, Ushiro-Lumb I, et al. The global impact of COVID-19 on solid organ transplantation: two years into a pandemic. Transplantation. 2022;106:1312\u201329.","journal-title":"Transplantation"},{"key":"2348_CR21","unstructured":"ACR COVID-19 Vaccine clinical guidance task force. COVID-19 vaccine clinical guidance summary for patients with rheumatic and musculoskeletal diseases. 2022. https:\/\/www.mhlw.go.jp\/content\/10900000\/000756894.pdf. Accessed 15 Jan 2023."},{"key":"2348_CR22","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfab064","author":"A Kronbichler","year":"2021","unstructured":"Kronbichler A, Anders HJ, Fernandez-Ju\u00e1rez GM, et al. Recommendations for the use of COVID-19 vaccines in patients with immune-mediated kidney diseases. Nephrol Dial Transplant. 2021. https:\/\/doi.org\/10.1093\/ndt\/gfab064.","journal-title":"Nephrol Dial Transplant"},{"key":"2348_CR23","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1111\/ajt.16851","volume":"22","author":"M Kantauskaite","year":"2022","unstructured":"Kantauskaite M, M\u00fcller L, Kolb T, et al. Intensity of mycophenolate mofetil treatment is associated with an impaired immune response to SARS-CoV-2 vaccination in kidney transplant recipients. Am J Transplant. 2022;22:634\u20139.","journal-title":"Am J Transplant"},{"key":"2348_CR24","doi-asserted-by":"publisher","first-page":"e238","DOI":"10.1097\/TP.0000000000004043","volume":"106","author":"T Morishita","year":"2022","unstructured":"Morishita T, Sakai A, Matsunami H. Seroconversions after withdrawal from mycophenolate mofetil in solid organ transplant recipients without a third dose of BNT162b2 mRNA coronavirus disease 2019 vaccine: a case series. Transplantation. 2022;106:e238\u20139.","journal-title":"Transplantation"},{"key":"2348_CR25","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/s41581-022-00617-5","volume":"18","author":"N Babel","year":"2022","unstructured":"Babel N, Hugo C, Westhoff TH. Vaccination in patients with kidney failure: lessons from COVID-19. Nat Rev Nephrol. 2022;18:708-23.26.","journal-title":"Nat Rev Nephrol"},{"key":"2348_CR26","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1053\/j.ajkd.2021.06.002","volume":"78","author":"JJ Broseta","year":"2021","unstructured":"Broseta JJ, Rodr\u00edguez-Espinosa D, Rodr\u00edguez N, et al. Humoral and cellular responses to mRNA-1273 and BNT162b2 SARS-CoV-2 vaccines administered to hemodialysis patients. Am J Kidney Dis. 2021;78:571\u201381.","journal-title":"Am J Kidney Dis"},{"key":"2348_CR27","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.37908","volume":"5","author":"EA Hermann","year":"2022","unstructured":"Hermann EA, Lee B, Balte PP, et al. Association of symptoms after COVID-19 vaccination with anti-SARS-CoV-2 antibody response in the framingham heart study. JAMA Netw Open. 2022;5: e2237908.","journal-title":"JAMA Netw Open"},{"key":"2348_CR28","doi-asserted-by":"publisher","first-page":"5736","DOI":"10.1038\/s41467-022-33378-7","volume":"13","author":"J Stowe","year":"2022","unstructured":"Stowe J, Andrews N, Kirsebom F, Ramsay M, Bernal JL. Effectiveness of COVID-19 vaccines against omicron and delta hospitalisation, a test negative case-control study. Nat Commun. 2022;13:5736.","journal-title":"Nat Commun"},{"key":"2348_CR29","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1056\/NEJMoa2108891","volume":"385","author":"J Lopez Bernal","year":"2021","unstructured":"Lopez Bernal J, Andrews N, Gower C, et al. Effectiveness of covid-19 vaccines against the B.1.617.2 (delta) variant. N Engl J Med. 2021;385:585\u201394.","journal-title":"N Engl J Med"},{"key":"2348_CR30","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.jiac.2021.11.021","volume":"28","author":"H Kato","year":"2022","unstructured":"Kato H, Miyakawa K, Ohtake N, et al. Antibody titers against the alpha, beta, gamma, and delta variants of SARS-CoV-2 induced by BNT162b2 vaccination measured using automated chemiluminescent enzyme immunoassay. J Infect Chemother. 2022;28:273\u20138.","journal-title":"J Infect Chemother"},{"key":"2348_CR31","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1056\/NEJMc2210648","volume":"387","author":"X Shen","year":"2022","unstructured":"Shen X, Chalkias S, Feng J, et al. Neutralization of SARS-CoV-2 Omicron BA.2.75 after mRNA-1273 vaccination. N Engl J Med. 2022;387:1234\u20136.","journal-title":"N Engl J Med"},{"key":"2348_CR32","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1111\/ajt.17020","volume":"22","author":"D Kumar","year":"2022","unstructured":"Kumar D, Hu Q, Samson R, et al. Neutralization against Omicron variant in transplant recipients after three doses of mRNA vaccine. Am J Transplant. 2022;22:2089\u201393.","journal-title":"Am J Transplant"},{"key":"2348_CR33","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1111\/ajt.17054","volume":"22","author":"L Benning","year":"2022","unstructured":"Benning L, Morath C, Bartenschlager M, et al. Neutralizing antibody response against the B.1.617.2 (delta) and the B.1.1.529 (omicron) variants after a third mRNA SARS-CoV-2 vaccine dose in kidney transplant recipients. Am J Transplant. 2022;22:1873\u201383.","journal-title":"Am J Transplant"},{"key":"2348_CR34","doi-asserted-by":"publisher","first-page":"e420","DOI":"10.1097\/TP.0000000000004219","volume":"106","author":"MP Cristelli","year":"2022","unstructured":"Cristelli MP, Nakamura MR, Viana LA, Tedesco-Silva H, Medina-Pestana J. The fourth dose of coronavac vaccine results in a small increase of seroconversion and antibody values among kidney transplant recipients. Transplantation. 2022;106:e420\u20131.","journal-title":"Transplantation"},{"key":"2348_CR35","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1056\/NEJMoa2116620","volume":"386","author":"MJ Levin","year":"2022","unstructured":"Levin MJ, Ustianowski A, De Wit S, et al. Intramuscular AZD7442 (tixagevimab-cilgavimab) for prevention of Covid-19. N Engl J Med. 2022;386:2188\u2013200.","journal-title":"N Engl J Med"},{"key":"2348_CR36","doi-asserted-by":"publisher","first-page":"e450","DOI":"10.1016\/S1470-2045(22)00372-2","volume":"23","author":"CL Lorentzen","year":"2022","unstructured":"Lorentzen CL, Haanen JB, Met \u00d6, Svane IM. Clinical advances and ongoing trials on mRNA vaccines for cancer treatment. Lancet Oncol. 2022;23:e450\u20138.","journal-title":"Lancet Oncol"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-023-02348-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10157-023-02348-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-023-02348-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T08:05:00Z","timestamp":1689581100000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10157-023-02348-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,24]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["2348"],"URL":"https:\/\/doi.org\/10.1007\/s10157-023-02348-8","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"type":"print","value":"1342-1751"},{"type":"electronic","value":"1437-7799"}],"subject":[],"published":{"date-parts":[[2023,4,24]]},"assertion":[{"value":"18 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional review board of the ethical committee at which the study was conducted (IRB approval number 5425) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The requirement for written informed consent was waived owing to the study\u2019s retrospective nature.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}